Late-Breaking Science Announced for TVT 2022

The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 12 studies as Late-Breaking Clinical Science and Featured Clinical Research. An annual meeting covering cutting-edge research and techniques...
13-May-2022 5:05 PM EDT Add to Favorites

TVT 2022 Program Now Available

The program for TVT 2022: The Structural Heart Summit is now available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions and will take...
10-May-2022 4:05 PM EDT Add to Favorites

Media Registration for TCT 2022 Now Open

Media registration is now open for TCT 2022 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will be held September 16-19, 2022, in Boston, Massachusetts at the Boston...
9-May-2022 2:00 PM EDT Add to Favorites

CTO Plus 2022 Will Feature Expanded Program

CTO Plus 2022 will feature the latest research and techniques for chronic total occlusions (CTO) as well as complex percutaneous coronary interventions (PCI). The annual conference, organized by the Cardiovascular Research Foundation (CRF), will...
10-Feb-2022 10:45 AM EST Add to Favorites

THT, CRF’s First-Ever Conference on Technology and Heart Failure Therapeutics, Will Take Place February 1-2, 2022

The program for THT 2022: Technology and Heart Failure Therapeutics is now available online. THT is the first-ever conference on technology and heart failure therapeutics from the Cardiovascular Research Foundation (CRF). The meeting, which...
13-Jan-2022 5:05 PM EST Add to Favorites

Lungpacer Medical Wins TCT 2021 Shark Tank Innovation Competition

The Cardiovascular Research Foundation (CRF) is pleased to announce that Lungpacer Medical, a clinical stage medical device company pioneering a diaphragm pacing therapy system for critically ill patients who require mechanical ventilation, has won...
22-Nov-2021 1:45 PM EST Add to Favorites

Trial Compares Two Devices Used For Percutaneous Left Atrial Appendage Closure

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure (LAAC) as evaluated by 45-day cardiac computed...
8-Nov-2021 11:40 AM EST Add to Favorites

Study Examines Differences in Gastrointestinal Effects of Antiplatelet Regimens After PCI

Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE trial found that nearly all patients receiving antiplatelet therapy developed evidence of abnormal gastrointestinal (GI) mucosal findings on capsule...
8-Nov-2021 11:30 AM EST Add to Favorites